Oladapo Bakare to Mice
This is a "connection" page, showing publications Oladapo Bakare has written about Mice.
Connection Strength
0.101
-
Khraiwesh MH, Lee CM, Brandy Y, Akinboye ES, Berhe S, Gittens G, Abbas MM, Ampy FR, Ashraf M, Bakare O. Antitrypanosomal activities and cytotoxicity of some novel imido-substituted 1,4-naphthoquinone derivatives. Arch Pharm Res. 2012 Jan; 35(1):27-33.
Score: 0.047
-
Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024 Aug; 177:117125.
Score: 0.028
-
Akinboye ES, Rosen MD, Bakare O, Denmeade SR. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives. Bioorg Med Chem. 2017 12 15; 25(24):6707-6717.
Score: 0.018
-
Anderson AJ, Nicholson JM, Bakare O, Butcher RJ, Wilson TL, Scott KR. Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides. Bioorg Med Chem. 2006 Feb 15; 14(4):997-1006.
Score: 0.008